{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:26:07Z","timestamp":1791231967622,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DZNE institutional budget"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.neulet.2014.07.049","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T06:20:10Z","timestamp":1407133210000},"page":"52-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Heterozygous Igf1r deletion does not ameliorate pathological features associated with polyglutamine-containing huntingtin fragment"],"prefix":"10.1016","volume":"580","author":[{"given":"Miriam","family":"Jakubik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa M.","family":"Floriddia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Nicotera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2014.07.049_bib0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2014.07.049_bib0010","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1038\/cddis.2011.112","article-title":"Neurodegenerative processes in Huntington's disease","volume":"2","author":"Bano","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neulet.2014.07.049_bib0015","doi-asserted-by":"crossref","first-page":"e26891","DOI":"10.1371\/journal.pone.0026891","article-title":"Does reduced IGF-1R signaling in Igf1r+\/\u2212 mice alter aging?","volume":"6","author":"Bokov","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neulet.2014.07.049_bib0020","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1126\/science.1124646","article-title":"Opposing activities protect against age-onset proteotoxicity","volume":"313","author":"Cohen","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neulet.2014.07.049_bib0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrn2474","article-title":"The insulin paradox: aging, proteotoxicity and neurodegeneration","volume":"9","author":"Cohen","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2014.07.049_bib0030","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cell.2009.11.014","article-title":"Reduced IGF-1 signaling delays age-associated proteotoxicity in mice","volume":"139","author":"Cohen","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2014.07.049_bib0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.201005144","article-title":"Protein homeostasis and aging in neurodegeneration","volume":"190","author":"Douglas","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neulet.2014.07.049_bib0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01298","article-title":"IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice","volume":"421","author":"Holzenberger","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2014.07.049_bib0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2014.07.049_bib0050","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.152161099","article-title":"The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans","volume":"99","author":"Morley","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2014.07.049_bib0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1172\/JCI45364","article-title":"The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease","volume":"121","author":"Munoz-Sanjuan","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2014.07.049_bib0060","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1172\/JCI46305","article-title":"IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease","volume":"121","author":"Sadagurski","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2014.07.049_bib0065","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2014.07.049_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/acel.12145","article-title":"Longevity effect of IGF-1R(+\/\u2212) mutation depends on genetic background-specific receptor activation","volume":"13","author":"Xu","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.neulet.2014.07.049_bib0075","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014006302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014006302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T05:30:30Z","timestamp":1538371830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394014006302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":15,"alternative-id":["S0304394014006302"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2014.07.049","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterozygous Igf1r deletion does not ameliorate pathological features associated with polyglutamine-containing huntingtin fragment","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2014.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}